Altre lingue Adicet Bio, Inc.

Azioni

ACET

US0070021086

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 06/05/2024			Variaz. 5gg	Var. 1 gen.
1,69 ^USD	+16,55%		+6,29%	-10,58%

22/04	Adicet Bio, Inc. evidenzia i dati preclinici che supportano la preparazione all'IND per ADI-270 in una presentazione orale al 27° Meeting Annuale ASGCT	CI
19/03	Adicet Bio, Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	30/04
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy 27th Annual Meeting	23/04
Adicet Bio Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting	22/04
Adicet Bio, Inc. Highlights Preclinical Data Supporting IND Readiness for ADI-270 in an Oral Presentation at the ASGCT 27th Annual Meeting	22/04
Adicet Bio to Participate in 2024 Canaccord Genuity Horizons in Oncology Virtual Conference	08/04
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	28/03
North American Morning Briefing : Markets Steady -2-	26/03
Adicet Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	19/03
Adicet Bio, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	19/03
Adicet Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Company Progress	19/03
Adicet Bio to Participate in a Fireside Chat at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference	11/03
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	01/03
Adicet Bio to Participate in a Fireside Chat at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	05/02
Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	31/01
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters Option to Purchase Additional Shares	26/01
Adicet Bio, Inc. Announces Closing of $98 Million Public Follow-On Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares	25/01
Sector Update: Health Care Stocks Mixed Premarket Tuesday	23/01
Adicet Bio Prices $85.2 Million Share Offering	23/01
Adicet Bio, Inc. Announces Pricing of Public Offering	23/01
Adicet Bio Launches Securities Offering; Shares Rise After-Hours	22/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Adicet Bio, Inc.

Azioni

ACET

US0070021086

Altre lingue

Filtri